SEEL logo

Seelos Therapeutics (SEEL) Net Income

Annual Net Income

-$37.88 M
+$35.65 M+48.48%

December 31, 2023

Summary

Performance

1-Year Change

+48.48%

3-Year Change

-98.32%

5-Year Change

-309.89%

15-Year Change

-11901.25%

SEEL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$321.00 K
SEEL annual net profit is currently <-9900.00% below its historical high of $321.00 thousand

3-Year Low

-$73.53 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELprofitabilitymetrics:

Annual Net Margin

-
SEEL annual net profit margin value is unknown

Annual Revenue

-
SEEL annual revenue value is unknown

Annual Gross Profit

-
SEEL annual gross profit value is unknown

Annual EPS

-$989.44
SEEL annual earnings per share is -$989.44

Quarterly Net Income

$1.71 M
+$4.37 M+164.19%

June 30, 2024

Summary

Performance

3-Month Change

+164.19%

1-Year Change

-83.71%

3-Year Change

+109.17%

5-Year Change

+191.79%

SEEL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.50 M
SEEL quarterly net profit is currently -83.71% below its historical high of $10.50 million

3-Year Low

-$29.50 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELprofitabilitymetrics:

Quarterly Net Margin

-
SEEL quarterly net profit margin value is unknown

Quarterly Revenue

-
SEEL quarterly revenue value is unknown

Quarterly Gross Profit

-
SEEL quarterly gross profit value is unknown

Quarterly EPS

$1.92
SEEL quarterly earnings per share is $1.92

TTM Net Income

$4.09 M
+$31.21 M+115.09%

June 30, 2024

Summary

Performance

3-Month Change

+115.09%

1-Year Change

+108.01%

3-Year Change

+105.56%

5-Year Change

+117.55%

SEEL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$5.01 M
SEEL TTM net profit is currently -18.33% below its historical high of $5.01 million

3-Year Low

-$82.14 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELprofitabilitymetrics:

Annual Net Margin

-
SEEL annual net profit margin value is unknown

TTM Revenue

-
SEEL TTM revenue value is unknown

TTM Gross Profit

-
SEEL TTM gross profit value is unknown

TTM EPS

-$475.52
SEEL TTM earnings per share is -$475.52

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$37.88 M
SEEL annual net profit is -$37.88 million

Annual Revenue

-
SEEL annual revenue value is unknown

Annual Cost Of Goods Sold

-
SEEL annual cost of goods sold value is unknown

Annual Operating Expenses

$40.50 M
SEEL annual total operating expenses is $40.50 million

Annual Interest Expense

$75.00 K
SEEL annual interest expense is $75.00 thousand

Annual Income Tax

-
SEEL annual income tax value is unknown

SEEL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+48.5%-83.7%+108.0%
3 y3 years-98.3%+109.2%+105.6%
5 y5 years-309.9%+191.8%+117.5%

SEEL Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+94.1%-83.7%-1824.9%at high-2107.7%
5 y5-year+98.3%+94.1%-83.7%-1824.9%at high-2107.7%
alltimeall time<-9999.0%+94.1%-83.7%-2176.7%-18.3%-2107.7%

Seelos Therapeutics Net Income History

DateAnnualQuarterlyTTM
Jun 2024
-
$1.71 M(-164.2%)
$4.09 M(-115.1%)
Mar 2024
-
-$2.66 M(-51.1%)
-$27.11 M(-28.4%)
Dec 2023
-$37.88 M(-48.5%)
-$5.45 M(-151.9%)
-$37.88 M(-25.8%)
Sep 2023
-
$10.50 M(-135.6%)
-$51.09 M(-37.1%)
Jun 2023
-
-$29.50 M(+119.6%)
-$81.19 M(+11.3%)
Mar 2023
-
-$13.43 M(-28.0%)
-$72.96 M(-0.8%)
Dec 2022
-$73.53 M(+11.3%)
-$18.66 M(-4.8%)
-$73.53 M(-10.5%)
Sep 2022
-
-$19.60 M(-7.8%)
-$82.14 M(+12.0%)
Jun 2022
-
-$21.27 M(+51.9%)
-$73.35 M(+20.4%)
Mar 2022
-
-$14.00 M(-48.6%)
-$60.93 M(-7.7%)
Dec 2021
-$66.05 M(+245.8%)
-$27.26 M(+152.0%)
-$66.05 M(+46.0%)
Sep 2021
-
-$10.81 M(+22.1%)
-$45.24 M(+17.5%)
Jun 2021
-
-$8.86 M(-53.7%)
-$38.51 M(+15.4%)
Mar 2021
-
-$19.12 M(+196.4%)
-$33.38 M(+74.8%)
Dec 2020
-$19.10 M(-62.7%)
-$6.45 M(+57.7%)
-$19.10 M(-18.1%)
Sep 2020
-
-$4.09 M(+9.7%)
-$23.31 M(+3.9%)
Jun 2020
-
-$3.73 M(-22.8%)
-$22.44 M(+9.1%)
Mar 2020
-
-$4.83 M(-54.7%)
-$20.57 M(-59.9%)
Dec 2019
-$51.26 M(+454.6%)
-$10.66 M(+230.9%)
-$51.26 M(+7.7%)
Sep 2019
-
-$3.22 M(+72.9%)
-$47.58 M(+4.7%)
Jun 2019
-
-$1.86 M(-94.8%)
-$45.46 M(-0.9%)
Mar 2019
-
-$35.51 M(+408.3%)
-$45.87 M(+263.1%)
Dec 2018
-$9.24 M(-2979.1%)
-$6.99 M(+536.9%)
-$12.63 M(+56.1%)
Sep 2018
-
-$1.10 M(-51.8%)
-$8.09 M(-25.3%)
Jun 2018
-
-$2.28 M(+0.3%)
-$10.83 M(+8.0%)
Mar 2018
-
-$2.27 M(-7.2%)
-$10.02 M(-3222.4%)
Dec 2017
$321.00 K(-104.3%)
-$2.45 M(-36.2%)
$321.00 K(-87.0%)
Sep 2017
-
-$3.83 M(+160.0%)
$2.47 M(-50.7%)
Jun 2017
-
-$1.47 M(-118.3%)
$5.01 M(+59.3%)
Mar 2017
-
$8.07 M(-2800.0%)
$3.15 M(-142.3%)
Dec 2016
-$7.43 M(-60.9%)
-$299.00 K(-76.8%)
-$7.43 M(-21.5%)
Sep 2016
-
-$1.29 M(-61.3%)
-$9.47 M(-28.3%)
Jun 2016
-
-$3.34 M(+33.3%)
-$13.21 M(-12.6%)
Mar 2016
-
-$2.50 M(+7.4%)
-$15.12 M(-20.5%)
Dec 2015
-$19.02 M(-12.7%)
-$2.33 M(-53.7%)
-$19.02 M(-44.0%)
Sep 2015
-
-$5.03 M(-4.0%)
-$33.98 M(+6.0%)
Jun 2015
-
-$5.25 M(-18.2%)
-$32.06 M(+28.6%)
Mar 2015
-
-$6.41 M(-62.9%)
-$24.94 M(+14.5%)
Dec 2014
-$21.79 M(+28.6%)
-$17.29 M(+455.3%)
-$21.79 M(+272.9%)
Sep 2014
-
-$3.11 M(-265.8%)
-$5.84 M(+2.2%)
Jun 2014
-
$1.88 M(-157.5%)
-$5.71 M(-50.4%)
Mar 2014
-
-$3.26 M(+142.5%)
-$11.53 M(-31.9%)
Dec 2013
-$16.94 M(-46.7%)
-$1.34 M(-54.9%)
-$16.94 M(-51.9%)
Sep 2013
-
-$2.98 M(-24.1%)
-$35.23 M(+1.4%)
Jun 2013
-
-$3.94 M(-54.6%)
-$34.74 M(-2.8%)
Mar 2013
-
-$8.67 M(-55.8%)
-$35.73 M(+12.5%)
Dec 2012
-$31.77 M(+75.4%)
-$19.64 M(+687.4%)
-$31.77 M(+88.8%)
Sep 2012
-
-$2.49 M(-49.4%)
-$16.82 M(+1.7%)
Jun 2012
-
-$4.93 M(+4.5%)
-$16.55 M(-14.8%)
Mar 2012
-
-$4.71 M(+0.5%)
-$19.42 M(+7.2%)
DateAnnualQuarterlyTTM
Dec 2011
-$18.12 M(-38.6%)
-$4.69 M(+111.3%)
-$18.12 M(-32.4%)
Sep 2011
-
-$2.22 M(-71.5%)
-$26.81 M(-1.4%)
Jun 2011
-
-$7.79 M(+128.5%)
-$27.20 M(+14.8%)
Mar 2011
-
-$3.41 M(-74.5%)
-$23.68 M(-19.7%)
Dec 2010
-$29.51 M(-7.9%)
-$13.39 M(+413.6%)
-$29.51 M(-36.2%)
Sep 2010
-
-$2.61 M(-39.1%)
-$46.23 M(+3.2%)
Jun 2010
-
-$4.28 M(-53.7%)
-$44.82 M(+6.8%)
Mar 2010
-
-$9.24 M(-69.3%)
-$41.96 M(+31.0%)
Dec 2009
-$32.04 M(+519.6%)
-$30.11 M(+2429.0%)
-$32.04 M(+3944.8%)
Sep 2009
-
-$1.19 M(-16.5%)
-$792.20 K(-70.0%)
Jun 2009
-
-$1.43 M(-308.3%)
-$2.64 M(-7.1%)
Mar 2009
-
$684.80 K(-39.9%)
-$2.84 M(-45.0%)
Dec 2008
-$5.17 M(-41.2%)
$1.14 M(-137.5%)
-$5.17 M(-42.6%)
Sep 2008
-
-$3.04 M(+86.7%)
-$9.01 M(+12.2%)
Jun 2008
-
-$1.63 M(-0.8%)
-$8.03 M(-4.3%)
Mar 2008
-
-$1.64 M(-39.1%)
-$8.39 M(-4.5%)
Dec 2007
-$8.79 M(+9.2%)
-$2.69 M(+30.6%)
-$8.79 M(+6.9%)
Sep 2007
-
-$2.06 M(+3.6%)
-$8.22 M(+0.9%)
Jun 2007
-
-$1.99 M(-2.4%)
-$8.14 M(+13.5%)
Mar 2007
-
-$2.04 M(-4.1%)
-$7.18 M(-10.8%)
Dec 2006
-$8.04 M(-47.9%)
-$2.13 M(+7.0%)
-$8.04 M(-12.2%)
Sep 2006
-
-$1.99 M(+94.3%)
-$9.16 M(-11.6%)
Jun 2006
-
-$1.02 M(-64.8%)
-$10.37 M(-24.5%)
Mar 2006
-
-$2.91 M(-10.5%)
-$13.72 M(-11.1%)
Dec 2005
-$15.44 M(-9.3%)
-$3.25 M(+1.7%)
-$15.44 M(-6.3%)
Sep 2005
-
-$3.19 M(-27.1%)
-$16.47 M(-8.5%)
Jun 2005
-
-$4.38 M(-5.3%)
-$18.00 M(+1.9%)
Mar 2005
-
-$4.62 M(+8.1%)
-$17.67 M(+3.8%)
Dec 2004
-$17.02 M(-1.2%)
-$4.28 M(-9.3%)
-$17.02 M(-12.1%)
Sep 2004
-
-$4.72 M(+16.5%)
-$19.37 M(+8.6%)
Jun 2004
-
-$4.05 M(+1.7%)
-$17.84 M(+0.4%)
Mar 2004
-
-$3.98 M(-39.9%)
-$17.76 M(+3.1%)
Dec 2003
-$17.23 M(-37.7%)
-$6.63 M(+108.3%)
-$17.23 M(-8.6%)
Sep 2003
-
-$3.18 M(-19.9%)
-$18.85 M(-16.4%)
Jun 2003
-
-$3.97 M(+15.1%)
-$22.55 M(-11.6%)
Mar 2003
-
-$3.45 M(-58.1%)
-$25.51 M(-7.7%)
Dec 2002
-$27.64 M(+70.9%)
-$8.25 M(+19.9%)
-$27.64 M(+9.2%)
Sep 2002
-
-$6.88 M(-0.9%)
-$25.31 M(+15.6%)
Jun 2002
-
-$6.94 M(+24.4%)
-$21.89 M(+18.1%)
Mar 2002
-
-$5.58 M(-5.7%)
-$18.54 M(+14.6%)
Dec 2001
-$16.17 M(+83.2%)
-$5.92 M(+71.1%)
-$16.17 M(+19.5%)
Sep 2001
-
-$3.46 M(-3.7%)
-$13.54 M(+13.5%)
Jun 2001
-
-$3.59 M(+11.7%)
-$11.92 M(+10.4%)
Mar 2001
-
-$3.21 M(-2.0%)
-$10.80 M(+22.4%)
Dec 2000
-$8.83 M(+252.2%)
-$3.28 M(+78.0%)
-$8.83 M(+59.1%)
Sep 2000
-
-$1.84 M(-25.4%)
-$5.55 M(+49.7%)
Jun 2000
-
-$2.47 M(+99.4%)
-$3.71 M(+199.4%)
Mar 2000
-
-$1.24 M
-$1.24 M
Dec 1999
-$2.51 M(-47.5%)
-
-
Dec 1998
-$4.78 M(+23.9%)
-
-
Dec 1997
-$3.86 M
-
-

FAQ

  • What is Seelos Therapeutics annual net profit?
  • What is the all time high annual net income for Seelos Therapeutics?
  • What is Seelos Therapeutics annual net income year-on-year change?
  • What is Seelos Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly net income year-on-year change?
  • What is Seelos Therapeutics TTM net profit?
  • What is the all time high TTM net income for Seelos Therapeutics?
  • What is Seelos Therapeutics TTM net income year-on-year change?

What is Seelos Therapeutics annual net profit?

The current annual net income of SEEL is -$37.88 M

What is the all time high annual net income for Seelos Therapeutics?

Seelos Therapeutics all-time high annual net profit is $321.00 K

What is Seelos Therapeutics annual net income year-on-year change?

Over the past year, SEEL annual net profit has changed by +$35.65 M (+48.48%)

What is Seelos Therapeutics quarterly net profit?

The current quarterly net income of SEEL is $1.71 M

What is the all time high quarterly net income for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly net profit is $10.50 M

What is Seelos Therapeutics quarterly net income year-on-year change?

Over the past year, SEEL quarterly net profit has changed by -$8.79 M (-83.71%)

What is Seelos Therapeutics TTM net profit?

The current TTM net income of SEEL is $4.09 M

What is the all time high TTM net income for Seelos Therapeutics?

Seelos Therapeutics all-time high TTM net profit is $5.01 M

What is Seelos Therapeutics TTM net income year-on-year change?

Over the past year, SEEL TTM net profit has changed by +$55.18 M (+108.01%)